Vimarsana
Biggest News Aggregation in the World

Page 3 - Michael Karin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Karin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Karin Today - Breaking & Trending Today

Unexpected discovery could inspire new strategies for preventing liver disease and cancer - Vimarsana News

Unexpected discovery could inspire new strategies for preventing liver disease and cancer

Liver cancer is the third leading cause of cancer death and the sixth most common cancer type worldwide.

New study flips the script on liver cancer - Vimarsana News

New study flips the script on liver cancer

UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.

Immune-Onc Therapeutics to Showcase Leadership in Myeloid Biology and Drug Development at Upcoming S - Vimarsana News

Immune-Onc Therapeutics to Showcase Leadership in Myeloid Biology and Drug Development at Upcoming S

PALO ALTO, Calif.--(BUSINESS WIRE)--#AML--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, announced today its plans to present on the company’s myeloid biology research and clinical stage programs at...

Survival rates for deadliest types of pancreatic cancer vary: Study - Vimarsana News

Survival rates for deadliest types of pancreatic cancer vary: Study

The most prevalent and fatal kind of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC). PDAC patients have a 5-year survival rate of only 7.1 per cen

Biochemical pathway leads to inflammation characteristic of autoimmune disease: study - Vimarsana News

Biochemical pathway leads to inflammation characteristic of autoimmune disease: study

Researchers describe the biochemical pathway that leads to inflammation characteristic of autoimmune diseases, which could lead to anti-inflammatory therapies